Bullboard - Stock Discussion Forum Bausch Health Companies Inc T.BHC

Alternate Symbol(s): BHC

Healthcare

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with... see more

Add To Watchlist

TSX:BHC - Post Discussion

Bausch Health Companies Inc > APMA Grants Seal of Approval for JUBLIA® (efinaconazole)

View:

Post by Betteryear2 on Dec 06, 2021 7:02am

APMA Grants Seal of Approval for JUBLIA® (efinaconazole)

LAVAL, QC, Dec. 6, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced JUBLIA® (efinaconazole) Topical Solution, 10%, a treatment for onychomycosis, a fungal infection of the toenails, has received the American Podiatric Medical Association (APMA) Seal of Approval. The APMA Seal of Approval is granted to products that promote good foot health and are of significant value when used in a consistently applied program of daily foot care and regular professional treatment.

https://www.prnewswire.com/news-releases/apma-grants-seal-of-approval-for-jublia-efinaconazole-topical-solution-10-301437700.html

299